The following investigators received rhBMP-2 data while the data were being made available between June 2013 and June 2015. Links to their protocols and publications are included.
| Date Data Request Approved | Principal Investigator | Institution | Name of Project | Protocol | Publications |
| October 10, 2013 | Amber Laurie, MS and Rochelle Fu, PhD | Oregon Health and Science University | Meta-analysis of the influence of patient characteristics on the effectiveness and harms of recombinant human bone morphogenetic protein-2 (rhBMP-2) in lumbar spinal fusion | Published in Spine September 15, 2016. Article available here. | |
| October 21, 2013 | Alex Hodkinson, MSc | University of Liverpool | Differences in the reporting of harms data in internal sponsored reports versus the corresponding published trial reports: Evaluating the safety reporting of rhBMP-2 in 17 Medtronic sponsored trials | Data Transferred, Project Not Pursued, Certificate of Data Destruction Received | |
| November 14, 2013 | Andrew Indresano, MD | University of Wisconsin-Madison | A Re-evaluation of Carcinogenicity and rhBMP-2: A Meta-Analysis of the Individual Participant-Level Data from the Yale University Open Data Access (YODA) Project | Data Transferred, Project Not Pursued, Certificate of Data Destruction Received | |
| January 16, 2014 | Vikas Patel, MD | University of Colorado | Meta-analysis of the Outcomes and Complications in the Spinal Surgery Population Receiving Recombinant Human Bone Morphogenetic Protein-2 vs. Those Receiving Iliac Crest Bone Graft | Published in Spine August 13, 2015. Article available here. |